A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleeding
Background: Uterine polyps cause abnormal bleeding in women and conventional practice is to remove them in hospital under general anaesthetic. Advances in technology make it possible to perform polypectomy in an outpatient setting, yet evidence of effectiveness is limited. Objectives: To test the hy...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2015-07-01
|
Series: | Health Technology Assessment |
Online Access: | https://doi.org/10.3310/hta19610 |
id |
doaj-8ae1ecd4aed44841b0f111717911d90e |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
T Justin Clark Lee J Middleton Natalie AM Cooper Lavanya Diwakar Elaine Denny Paul Smith Laura Gennard Lynda Stobert Tracy E Roberts Versha Cheed Tracey Bingham Sue Jowett Elizabeth Brettell Mary Connor Sian E Jones Jane P Daniels |
spellingShingle |
T Justin Clark Lee J Middleton Natalie AM Cooper Lavanya Diwakar Elaine Denny Paul Smith Laura Gennard Lynda Stobert Tracy E Roberts Versha Cheed Tracey Bingham Sue Jowett Elizabeth Brettell Mary Connor Sian E Jones Jane P Daniels A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleeding Health Technology Assessment |
author_facet |
T Justin Clark Lee J Middleton Natalie AM Cooper Lavanya Diwakar Elaine Denny Paul Smith Laura Gennard Lynda Stobert Tracy E Roberts Versha Cheed Tracey Bingham Sue Jowett Elizabeth Brettell Mary Connor Sian E Jones Jane P Daniels |
author_sort |
T Justin Clark |
title |
A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleeding |
title_short |
A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleeding |
title_full |
A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleeding |
title_fullStr |
A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleeding |
title_full_unstemmed |
A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleeding |
title_sort |
randomised controlled trial of outpatient versus inpatient polyp treatment (opt) for abnormal uterine bleeding |
publisher |
NIHR Journals Library |
series |
Health Technology Assessment |
issn |
1366-5278 2046-4924 |
publishDate |
2015-07-01 |
description |
Background: Uterine polyps cause abnormal bleeding in women and conventional practice is to remove them in hospital under general anaesthetic. Advances in technology make it possible to perform polypectomy in an outpatient setting, yet evidence of effectiveness is limited. Objectives: To test the hypothesis that in women with abnormal uterine bleeding (AUB) associated with benign uterine polyp(s), outpatient polyp treatment achieved as good, or no more than 25% worse, alleviation of bleeding symptoms at 6 months compared with standard inpatient treatment. The hypothesis that response to uterine polyp treatment differed according to the pattern of AUB, menopausal status and longer-term follow-up was tested. The cost-effectiveness and acceptability of outpatient polypectomy was examined. Design: A multicentre, non-inferiority, randomised controlled trial, incorporating a cost-effectiveness analysis and supplemented by a parallel patient preference study. Patient acceptability was evaluated by interview in a qualitative study. Setting: Outpatient hysteroscopy clinics and inpatient gynaecology departments within UK NHS hospitals. Participants: Women with AUB – defined as heavy menstrual bleeding (formerly known as menorrhagia) (HMB), intermenstrual bleeding or postmenopausal bleeding – and hysteroscopically diagnosed uterine polyps. Interventions: We randomly assigned 507 women, using a minimisation algorithm, to outpatient polypectomy compared with conventional inpatient polypectomy as a day case in hospital under general anaesthesia. Main outcome measures: The primary outcome was successful treatment at 6 months, determined by the woman’s assessment of her bleeding. Secondary outcomes included quality of life, procedure feasibility, acceptability and cost per quality-adjusted life-year (QALY) gained. Results: At 6 months, 73% (166/228) of women who underwent outpatient polypectomy were successfully treated compared with 80% (168/211) following inpatient polypectomy [relative risk (RR) 0.91, 95% confidence interval (CI) 0.82 to 1.02]. The lower end of the CIs showed that outpatient polypectomy was at most 18% worse, in relative terms, than inpatient treatment, within the 25% margin of non-inferiority set at the outset of the study. By 1 and 2 years the corresponding proportions were similar producing RRs close to unity. There was no evidence that the treatment effect differed according to any of the predefined subgroups when treatments by variable interaction parameters were examined. Failure to completely remove polyps was higher (19% vs. 7%; RR 2.5, 95% CI 1.5 to 4.1) with outpatient polypectomy. Procedure acceptability was reduced with outpatient compared with inpatient polyp treatment (83% vs. 92%; RR 0.90, 95% CI 0.84 to 0.97). There were no significant differences in quality of life. The incremental cost-effectiveness ratios at 6 and 12 months for inpatient treatment were £1,099,167 and £668,800 per additional QALY, respectively. Conclusions: When treating women with AUB associated with uterine polyps, outpatient polypectomy was non-inferior to inpatient polypectomy at 6 and 12 months, and relatively cost-effective. However, patients need to be aware that failure to remove a polyp is more likely with outpatient polypectomy and procedure acceptability lower. Trial registration: Current Controlled Trials ISRCTN 65868569. Funding: This project was funded by the NIHR Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 19, No. 61. See the NIHR Journals Library website for further project information. |
url |
https://doi.org/10.3310/hta19610 |
work_keys_str_mv |
AT tjustinclark arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT leejmiddleton arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT natalieamcooper arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT lavanyadiwakar arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT elainedenny arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT paulsmith arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT lauragennard arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT lyndastobert arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT tracyeroberts arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT vershacheed arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT traceybingham arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT suejowett arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT elizabethbrettell arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT maryconnor arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT sianejones arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT janepdaniels arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT tjustinclark randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT leejmiddleton randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT natalieamcooper randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT lavanyadiwakar randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT elainedenny randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT paulsmith randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT lauragennard randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT lyndastobert randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT tracyeroberts randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT vershacheed randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT traceybingham randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT suejowett randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT elizabethbrettell randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT maryconnor randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT sianejones randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding AT janepdaniels randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding |
_version_ |
1724834158703804416 |
spelling |
doaj-8ae1ecd4aed44841b0f111717911d90e2020-11-25T02:29:16ZengNIHR Journals LibraryHealth Technology Assessment1366-52782046-49242015-07-01196110.3310/hta1961006/404/84A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleedingT Justin Clark0Lee J Middleton1Natalie AM Cooper2Lavanya Diwakar3Elaine Denny4Paul Smith5Laura Gennard6Lynda Stobert7Tracy E Roberts8Versha Cheed9Tracey Bingham10Sue Jowett11Elizabeth Brettell12Mary Connor13Sian E Jones14Jane P Daniels15Birmingham Women’s Hospital NHS Foundation Trust, Edgbaston, Birmingham, UKBirmingham Clinical Trials Unit, University of Birmingham, Birmingham, UKWomen’s Health Research Unit, The Blizard Institute, Queen Mary University of London, London, UKHealth Economics Unit, School of Health and Population Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UKCentre for Health and Social Care Research, Faculty of Health, Birmingham City University, Edgbaston, Birmingham, UKBirmingham Women’s Hospital NHS Foundation Trust, Edgbaston, Birmingham, UKBirmingham Clinical Trials Unit, University of Birmingham, Birmingham, UKCentre for Health and Social Care Research, Faculty of Health, Birmingham City University, Edgbaston, Birmingham, UKHealth Economics Unit, School of Health and Population Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UKBirmingham Clinical Trials Unit, University of Birmingham, Birmingham, UKBirmingham Women’s Hospital NHS Foundation Trust, Edgbaston, Birmingham, UKHealth Economics Unit, School of Health and Population Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UKBirmingham Clinical Trials Unit, University of Birmingham, Birmingham, UKJessop Wing, Sheffield Teaching Hospitals NHS Trust, Sheffield, UKBradford Teaching Hospitals NHS Foundation Trust, Bradford, UKSchool of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UKBackground: Uterine polyps cause abnormal bleeding in women and conventional practice is to remove them in hospital under general anaesthetic. Advances in technology make it possible to perform polypectomy in an outpatient setting, yet evidence of effectiveness is limited. Objectives: To test the hypothesis that in women with abnormal uterine bleeding (AUB) associated with benign uterine polyp(s), outpatient polyp treatment achieved as good, or no more than 25% worse, alleviation of bleeding symptoms at 6 months compared with standard inpatient treatment. The hypothesis that response to uterine polyp treatment differed according to the pattern of AUB, menopausal status and longer-term follow-up was tested. The cost-effectiveness and acceptability of outpatient polypectomy was examined. Design: A multicentre, non-inferiority, randomised controlled trial, incorporating a cost-effectiveness analysis and supplemented by a parallel patient preference study. Patient acceptability was evaluated by interview in a qualitative study. Setting: Outpatient hysteroscopy clinics and inpatient gynaecology departments within UK NHS hospitals. Participants: Women with AUB – defined as heavy menstrual bleeding (formerly known as menorrhagia) (HMB), intermenstrual bleeding or postmenopausal bleeding – and hysteroscopically diagnosed uterine polyps. Interventions: We randomly assigned 507 women, using a minimisation algorithm, to outpatient polypectomy compared with conventional inpatient polypectomy as a day case in hospital under general anaesthesia. Main outcome measures: The primary outcome was successful treatment at 6 months, determined by the woman’s assessment of her bleeding. Secondary outcomes included quality of life, procedure feasibility, acceptability and cost per quality-adjusted life-year (QALY) gained. Results: At 6 months, 73% (166/228) of women who underwent outpatient polypectomy were successfully treated compared with 80% (168/211) following inpatient polypectomy [relative risk (RR) 0.91, 95% confidence interval (CI) 0.82 to 1.02]. The lower end of the CIs showed that outpatient polypectomy was at most 18% worse, in relative terms, than inpatient treatment, within the 25% margin of non-inferiority set at the outset of the study. By 1 and 2 years the corresponding proportions were similar producing RRs close to unity. There was no evidence that the treatment effect differed according to any of the predefined subgroups when treatments by variable interaction parameters were examined. Failure to completely remove polyps was higher (19% vs. 7%; RR 2.5, 95% CI 1.5 to 4.1) with outpatient polypectomy. Procedure acceptability was reduced with outpatient compared with inpatient polyp treatment (83% vs. 92%; RR 0.90, 95% CI 0.84 to 0.97). There were no significant differences in quality of life. The incremental cost-effectiveness ratios at 6 and 12 months for inpatient treatment were £1,099,167 and £668,800 per additional QALY, respectively. Conclusions: When treating women with AUB associated with uterine polyps, outpatient polypectomy was non-inferior to inpatient polypectomy at 6 and 12 months, and relatively cost-effective. However, patients need to be aware that failure to remove a polyp is more likely with outpatient polypectomy and procedure acceptability lower. Trial registration: Current Controlled Trials ISRCTN 65868569. Funding: This project was funded by the NIHR Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 19, No. 61. See the NIHR Journals Library website for further project information.https://doi.org/10.3310/hta19610 |